1Yoshinori Itoh,Yoshikazu Koshita,Minoru Takahashi,Naoki Watanabe,Yutaka Kohgo,Yoshiro Niitsu. Characterization of tumor-necrosis-factor-gene-transduced tumor-infiltrating lymphocytes from ascitic fluid of cancer patients: analysis of cytolytic activity, growth rate, adhesion molecule expression and cytokine production[J] 1995,Cancer Immunology Immunotherapy(2):95～102
2Diana Risin,Eugenie S. Kleinerman,Yasuiki Umezu,Roland P. Pizzini,Charles M. Balch,Neal R. Pellis. Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated myramyl-tripeptide-phosphatidylethanolamine[J] 1995,Cancer Immunology Immunotherapy(1):57～64
3Eugène Roussel,Marie-Claude Gingras,Elizabeth A. Grimm,Jack A. Roth. High expression of adhesion molecules/activation markers with little interleukin-2, interferon γ, and tumor necrosis factor β gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma[J] 1995,Cancer Immunology Immunotherapy(1):1～9
5Michael L. Salgaller,Jeffrey S. Weber,Scott Koenig,John R. Yannelli,Steven A. Rosenberg. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide[J] 1994,Cancer Immunology Immunotherapy(2):105～116
